Tudor Investment Corp ET AL reduced its position in LivaNova PLC (NASDAQ:LIVN) by 56.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,428 shares of the company’s stock after selling 9,459 shares during the period. Tudor Investment Corp ET AL’s holdings in LivaNova PLC were worth $364,000 as of its most recent filing with the SEC.
Other hedge funds have also added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund increased its stake in LivaNova PLC by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 15,360 shares of the company’s stock worth $753,000 after buying an additional 200 shares in the last quarter. Investment Counselors of Maryland LLC acquired a new stake in LivaNova PLC during the first quarter worth $4,630,000. Janney Montgomery Scott LLC increased its stake in LivaNova PLC by 30.6% in the first quarter. Janney Montgomery Scott LLC now owns 11,144 shares of the company’s stock worth $546,000 after buying an additional 2,614 shares in the last quarter. Glen Harbor Capital Management LLC increased its stake in LivaNova PLC by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock worth $147,000 after buying an additional 306 shares in the last quarter. Finally, Bollard Group LLC acquired a new stake in LivaNova PLC during the first quarter worth $1,715,000. 73.01% of the stock is currently owned by hedge funds and other institutional investors.
Shares of LivaNova PLC (NASDAQ:LIVN) opened at 61.34 on Friday. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $63.21. The stock’s market capitalization is $3.00 billion. The company’s 50-day moving average is $61.55 and its 200 day moving average is $54.12.
LivaNova PLC (NASDAQ:LIVN) last posted its earnings results on Wednesday, May 3rd. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. LivaNova PLC had a positive return on equity of 8.77% and a negative net margin of 0.92%. The company had revenue of $285.10 million for the quarter. Equities research analysts predict that LivaNova PLC will post $3.11 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/07/29/tudor-investment-corp-et-al-decreases-stake-in-livanova-plc-nasdaqlivn-updated.html.
Separately, BidaskClub downgraded shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. LivaNova PLC currently has a consensus rating of “Hold” and an average target price of $61.33.
In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $61.55, for a total value of $61,550.00. Following the transaction, the director now owns 56,437 shares in the company, valued at $3,473,697.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Hugh M. Morrison sold 3,215 shares of LivaNova PLC stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $55.89, for a total value of $179,686.35. Following the completion of the transaction, the director now owns 2,000 shares in the company, valued at approximately $111,780. The disclosure for this sale can be found here. Insiders sold 6,215 shares of company stock worth $360,526 in the last quarter. 0.28% of the stock is owned by insiders.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.
